DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Babu G, Saldanha SC, Kuntegowdanahalli Chinnagiriyappa L. et al
The efficacy, safety, and cost benefit of olanzapine versus aprepitant in highly emetogenic chemotherapy: a pilot study from South India.
Chemother Res Pract 2016; 3439707
Access:
We do not assume any responsibility for the contents of the web pages of other providers.